← All stocks

ABEONA THERAPEUTICS INC.

ABEO Net selling

CIK 0000318306 #3433 in the set updated 18 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$87.97K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$87.97K

1 of 1 sales

Net

−$87.97K

−$87.97K against sales at will

By person

13 insiders · 1 transaction

11.5×

Vishwas Seshadri holds 11.5 times base salary in stock. $7.66M of shares against $662.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Vishwas Seshadri last reported holding, valued at $5.86, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Alvino Mark

Director

—

$87.97K (1)

−$87.97K

62,065

0.1085%

$363.97K

−14.1%

Seshadri Vishwas

Chief Executive Officer

—

1,306,108

2.28%

$7.66M

+41.5%

Vazzano Joseph Walter

Chief Financial Officer

—

492,079

0.8605%

$2.89M

+32.4%

O'Malley Brendan M.

SVP, Chief Legal Officer

—

427,953

0.7484%

$2.51M

+52.6%

Vasanthavada Madhav

Chief Commercial Officer

—

290,623

0.5082%

$1.70M

+14.1%

Amoroso Michael

Director

—

217,779

0.3808%

$1.28M

+50.9%

Charles Faith L.

Director

—

176,407

0.3085%

$1.03M

+55.1%

Wuchterl Donald A.

Director

—

167,935

0.2937%

$984.84K

+46.7%

Alland Leila

Director

—

162,614

0.2844%

$953.63K

+37.5%

Silverstein Christine Berni

Director

—

119,562

0.2091%

$701.16K

+22.7%

Zeiher Bernhardt G

Director

—

84,458

0.1477%

$495.30K

+664.7%

Crombez Eric

Director

—

37,313

0.0653%

$218.82K

+237.9%

Goldan Keith A.

Director

—

32,751

0.0573%

$192.06K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Alvino Mark

1 Sep 2026

Director

Sell

15,000

$5.86

$87.97K

Show all 1 transactions →

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 0

History held since 28 Sep 2016